VidPrevtyn Beta Evrópusambandið - íslenska - EMA (European Medicines Agency)

vidprevtyn beta

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - bóluefni - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 og 5. 1 in product information document). notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.

Enjaymo Evrópusambandið - íslenska - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - Ónæmisbælandi lyf - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Typhim Vi Stungulyf, lausn 25 míkróg/0,5 ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

typhim vi stungulyf, lausn 25 míkróg/0,5 ml

sanofi pasteur* - salmonella typhi vi antigen - stungulyf, lausn - 25 míkróg/0,5 ml

Stilnoct Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stilnoct filmuhúðuð tafla 10 mg

sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg

Stamaril Stungulyfsstofn og leysir, dreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stamaril stungulyfsstofn og leysir, dreifa

sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa

Flagyl Leggangastíll 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flagyl leggangastíll 500 mg

sanofi-aventis norge as - metronidazolum inn - leggangastíll - 500 mg

Pentavac Stungulyfsstofn og dreifa, dreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pentavac stungulyfsstofn og dreifa, dreifa

sanofi pasteur* - filamentous haemagglutinin; poliovirus inactivated type 2; poliovirus inactivated type 3; diphtheria toxoid; tetanus toxoid; poliovirus inactivated type 1; pertussis toxoid; haemophilus influenzae type b - stungulyfsstofn og dreifa, dreifa

Solian Tafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

solian tafla 200 mg

sanofi-aventis norge as - amisulpridum inn - tafla - 200 mg

Solian Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

solian tafla 50 mg

sanofi-aventis norge as - amisulpridum inn - tafla - 50 mg

VaxigripTetra Stungulyf, dreifa í áfylltri sprautu 15 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg

sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg